Endometriosis and Psychological Support

May 13, 2019 updated by: Renato Seracchioli, IRCCS Azienda Ospedaliero-Universitaria di Bologna

The Impact of Psychological Support During the Hospitalization in Women With Endometriosis

Endometriosis is a common disease, causing significant pain (dysmenorrhea, dysuria, dyspnea, dyspareunia, and chronic pelvic pain) and infertility, drastically reducing patients' quality of life.

Endometriosis surgery is often a stressful event for the patient. For that reason, psychological support can improve patients' general health state.

Study Overview

Detailed Description

Patients with clinical and trans-vaginal / abdominal ultrasound diagnosis of endometriosis, undergoing surgery for the removal of endometriotic lesions are included in the study.

Psychological support is offered to all women one month before and one month after surgery. A group of patients will receive intensive psychological support during hospitalization.

Patients are divided into 2 groups:

Group A: patients receiving intensive psychological support during hospitalization

Group B: patients not receiving intensive psychological support during hospitalization

After surgery, patients will be included in the post-operative follow-up, as usual in the investigator's clinical practice.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • BO
      • Bologna, BO, Italy, 40138
        • Recruiting
        • Azienda Ospedaliero-Universitaria Sant'Orsola Malpighi
        • Contact:
        • Principal Investigator:
          • Renato Seracchioli, MD
        • Principal Investigator:
          • Alessandro Arena, MD
        • Principal Investigator:
          • Federica Manzara, MD
        • Principal Investigator:
          • Chiara Ferracuti, Psychologist
        • Sub-Investigator:
          • Manuela Mastronardi, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients undergoing surgery for endometriosis
  • Patients that have signed an informed consent

Exclusion Criteria:

  • Patients with active or history of psychological/psychiatric diseases
  • Patients that refuse psychological support

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Group A (intensive support)
Patients that receive standard and intensive psychological support during hospitalization
Two meeting with a psychologist during the hospitalization (the first two days after surgery; the second one at the moment of the hospitalization discharge)
Two meetings with a psychologist: the first meeting is one month before surgery; the second meeting is one month after surgery
Other: Group B (standard support)
Patients that receive only standard psychological support during hospitalization
Two meetings with a psychologist: the first meeting is one month before surgery; the second meeting is one month after surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General health state
Time Frame: From one month before surgery until the hospitalization discharge; assessed up to 7 days after surgery
Measurement of quality of life of patients underwent surgery for endometriosis, using the validated questionnaire Clinical Outcomes In Routine Evaluation, with a total score from 1 (the best outcome) to more than 85 (the worse outcome), where: 1 to 20 is Healthy; 21 to 33 is Low level; 34 to 50 is Mild level; 51 to 67 is Moderate level; 68 to 84 is Moderate to severe level; more than 85 is Severe level. The questionnaire is submitted one month before surgery and at the hospitalization discharge.
From one month before surgery until the hospitalization discharge; assessed up to 7 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain: Numeric Rating Scale
Time Frame: Postoperative: at the hospitalization discharge (assessed up to 7 days after surgery) and one month after surgery
Evaluation of postoperative pain using Numeric Rating Scale, from 0 to 10 (where 0 is no pain and 10 is the worse pain ever).
Postoperative: at the hospitalization discharge (assessed up to 7 days after surgery) and one month after surgery
Anxiety and Depression
Time Frame: From one month before surgery until the hospitalization discharge; assessed up to 7 days after surgery
Measurement of anxiety and depression of patients underwent surgery for endometriosis, using the validated questionnaire Hospital Anxiety and Depression Scale, from 0 (the best outcome) to 21 (the worse outcome), where: 0 to 7 is Normal; 8 to 10 is Borderline case; 11 to 21 is Abnormal.
From one month before surgery until the hospitalization discharge; assessed up to 7 days after surgery
Stress
Time Frame: From one month before surgery until the hospitalization discharge; assessed up to 7 days after surgery
Measurement of stress in patients underwent surgery for endometriosis, using the validated questionnaire Perceived Stress Scale, from 0 (the best outcome) to 40 (the worse outcome), where scores ranging from 0-13 would be considered low stress; scores ranging from 14-26 would be considered moderate stress; scores ranging from 27-40 would be considered high perceived stress.
From one month before surgery until the hospitalization discharge; assessed up to 7 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Anticipated)

August 1, 2019

Study Completion (Anticipated)

September 1, 2019

Study Registration Dates

First Submitted

January 24, 2019

First Submitted That Met QC Criteria

February 1, 2019

First Posted (Actual)

February 4, 2019

Study Record Updates

Last Update Posted (Actual)

May 15, 2019

Last Update Submitted That Met QC Criteria

May 13, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ENDO.PS.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endometriosis

Clinical Trials on Intensive psychological support

3
Subscribe